胰腺导管腺癌(pancreatic ductal ...

A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic ...

引言在与癌症的博弈中，胰腺导管腺癌（Pancreatic Ductal Adenocarcinoma, ...

PDAC, an aggressive and often difficult-to-diagnose cancer, frequently spreads before detection. The study, published in the ...

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related mortality worldwide. Current treatment modalities are few or ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit writes about the critical federal funding at risk and what this ...

Pancreatic cancer is one of the leading causes of cancer-related mortality, with pancreatic ductal adenocarcinoma (PDAC) ...

The trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.

Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced positive results from the VERIFI study, the second clinical validation study of its next-generation ...

Explore the medical isotopes market growth, trends, innovations, and applications in healthcare, diagnostics, and therapy. Discover key drivers, challenges, and opportunities shaping the industry.

Encouraging preclinical data supporting the use of DNase-based technology to target NETosis and address difficult to treat cancers ...